ACEL
Accel Entertainment, Inc.
ACEL offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN
Amazon.com, Inc.
AMZN has the edge over ACEL overall, supported by stronger valuation and stronger modeled upside.
ACEL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
ACEL's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ACEL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $12.09 | -13% |
| Forward | 16x | $13.83 | — |
| Current | 18x | $13.83 | — |
| Fair | 21x | $15.87 | +15% |
| Expensive | 28x | $20.96 | +52% |
Historical ranges are pointers, not guarantees.
ACEL's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ACEL in the historical PE scenario, which offers more potential upside but is not a forecast.
ACEL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
ACEL has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ACEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | +16% |
| Q3 2026 | $0.76 | +52% |
| Q2 2026 | $0.67 | +68% |
| Q1 2026 | $0.60 | +22% |
| Q4 2025 | $0.60 | +46% |
| Q3 2025 | $0.50 | -2% |
| Q2 2025 | $0.40 | -30% |
| Q1 2025 | $0.49 | -3.9% |
| Q4 2024 | $0.41 | -23% |
ACEL earned $0.76 per share over the past year, up 52% from the year before.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ACEL on earnings, with more consistent year-over-year improvement.
ACEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $363.6M | +10% |
| Q2 2026 | $368.1M | +9.6% |
| Q1 2026 | $351.6M | +8.5% |
| Q4 2025 | $341.4M | +7.5% |
| Q3 2025 | $329.7M | +9.1% |
| Q2 2025 | $335.9M | +8.6% |
| Q1 2025 | $323.9M | +7.3% |
| Q4 2024 | $317.5M | +6.9% |
ACEL's revenue has grown year over year for 23 quarters in a row: $364M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | +0.2 points |
| Q2 2026 | 8.7% | +0.7 points |
| Q1 2026 | 7.7% | -0.3 points |
| Q4 2025 | 8.7% | +2.1 points |
| Q3 2025 | 7.7% | +0.5 points |
| Q2 2025 | 8% | +0.7 points |
| Q1 2025 | 8% | -0.5 points |
| Q4 2024 | 6.5% | -2 points |
ACEL's operating margin was 7.9% last quarter, about level with the same quarter a year ago.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ACEL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over ACEL on profitability, with a higher operating margin.
ACEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | +77% |
| Q2 2026 | $8.9M | +$15.1M |
| Q1 2026 | $19.9M | +10% |
| Q4 2025 | $16M | +670% |
| Q3 2025 | $34.2M | +3.4% |
| Q2 2025 | -$6.2M | -155% |
| Q1 2025 | $18M | +122% |
| Q4 2024 | $2.1M | -89% |
ACEL has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ACEL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -15K shares |
| 1 year | -3.1% | -2.7M shares |
| 3 years | -4.3% | -3.7M shares |
| 5 years | -12% | -11.3M shares |
| Available history | +6.9% | +5.4M shares |
ACEL has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $7.2M |
| Q2 2026 | $5.6M |
| Q1 2026 | $12.1M |
| Q4 2025 | $16.2M |
| Q3 2025 | $6.8M |
| Q2 2025 | $6.7M |
| Q1 2025 | $10.2M |
| Q4 2024 | $4M |
ACEL spent $41M buying back its own shares over the past year, up 48% from the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ACEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 2.0x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.3x | Moderate |
ACEL's net debt is about 1.6 years of its operating earnings (EBITDA), down from 2.0 years a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over ACEL on leverage, with a lower net debt burden relative to earnings.
ACEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.7 | Neutral |
| Stochastic | 74.0 | Neutral |
ACEL's weekly RSI is 70 (neutral) and its Stochastic is 74 (neutral).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ACEL PE vs Consumer Cyclical Sector
| Metric | ACEL | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 1% above |
| PE % | 27 | 47 | 20 pts below |
ACEL has the edge over AMZN on valuation relative to its sector.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ACEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.7 | 18% above |
| 20 week MA | $11.9 | 16% above |
| 50 week MA | $11.8 | 18% above |
| 100 week MA | $11.4 | 21% above |
| 200 week MA | $10.9 | 26% above |
ACEL is in an uptrend: it's above all five of its weekly moving averages, and 26% above its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ACEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.3 | $10.9 | -12% |
| 2021 | $10.9 | $13.2 | +21% |
| 2022 | $13.2 | $7.57 | -43% |
| 2023 | $7.57 | $10.3 | +36% |
| 2024 | $10.3 | $10.6 | +3.6% |
| 2025 | $10.6 | $11.7 | +10% |
| 2026 YTD | $11.7 | $13.8 | +18% |
ACEL has the edge over AMZN on returns for 2026, with the stronger performance.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.